TheStreet) -- STOCK COMMENTS / EPS CHANGES AMN Healthcare Services ( AHS) price target raised at Citi to $9 from $7. In-line 4Q10 results, revenue back on track, Citigroup said. Maintain Hold rating. TD Ameritrade ( AMTD) numbers raised at Goldman. Shares of AMTD now seen reaching $24, according to Goldman Sachs. Estimates also increased, as the company is attracting more assets and seeing better trading volume. Buy rating. Brown/Forman ( BF.B) numbers upped at Goldman. BF.B estimates were boosted through 2013, Goldman Sachs said. Company raised its guidance. Neutral rating and new $73 price target. Baker Hughes ( BHI) price target lifted at Citi to $69 from $63. Near-term disruptions do not impact long-term story, Citigroup said. Maintain Hold rating. Dick's Sporting ( DKS) numbers boosted at Goldman. Shares of DKS now seen reaching $44, according to Goldman Sachs. Estimates also upped, and higher sales are driving margins. Neutral rating. Emdeon ( EM) estimates, target increased at Goldman. EM estimates were raised through 2012, Goldman Sachs said. Company is realizing higher margins. Neutral rating and new $16 price target. Endo Pharmaceuticals ( ENDP) price target higher at Credit Suisse to $36 from $34 following strong 4Q10 results, Credit Suisse said. Maintain Neutral rating. Boston Beer ( SAM) numbers increased at Goldman through 2013, Goldman Sachs said. Company is realizing lower manufacturing costs. Neutral rating and new $94 price target. Suntech Power ( STP) numbers boosted at Jefferies. Shares of STP now seen reaching $10, according to Jefferies. Estimates also upped, as the company is seeing better earnings momentum. Hold rating. Texas Instruments ( TXN) numbers boosted at UBS. Shares of TXN now seen reaching $36, according to UBS. Estimates also upped, as the company is seeing a more favorable sales mix.